CYXONE
Cyxone AB is a Swedish biotech company founded in 2015 with the aim of developing drugs with cyclotide technology that can considerably improve quality of life for people living with severe autoimmune diseases. The company is run via an international network of different experts within research, development and manufacturing, including the scientific founders in Austria and Germany. The driving force is to develop a strong drug portfolio with innovative and effective treatment methods to decreas... e the side effects and slow down the disease development in order to improve quality of life for people affected by severe immune-related disorders. Cyxone’s portfolio is based on a solid research platform with a type of biological molecules that have proven to work well as a drug for humans. The company’s development portfolio comprises Rabeximod in clinical phase II program for rheumatoid arthritis (RA) and T20K that is in clinical phase I for multiple sclerosis (MS). In future, Cyxone will also use its cyclotide technology to develop new structures that may prove beneficial for patients in other disease areas.
CYXONE
Industry:
Biotechnology
Address:
Malmö, Skane Lan, Sweden
Country:
Sweden
Website Url:
http://www.cyxone.com
Total Employee:
1+
Status:
Active
Contact:
+46 (0)723 816 168
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network Font Awesome Apache
Similar Organizations
Current Employees Featured
Official Site Inspections
http://www.cyxone.com Semrush global rank: 4.93 M Semrush visits lastest month: 1.74 K
- Host name: webcluster1.wordpresspod2-cph3.one.com
- IP address: 77.111.241.74
- Location: Denmark
- Latitude: 55.7123
- Longitude: 12.0564
- Timezone: Europe/Copenhagen
More informations about "Cyxone"
Cyxone - Crunchbase Company Profile & Funding
Organization. Cyxone . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. ... Cyxone AB is a Swedish biotech company founded in 2015 with the aim of …See details»
Management - Cyxone
Cyxone’s executive management team consists of experienced experts with solid knowledge in the fields of drug development, business development and financing in innovative biotech …See details»
Corporate governance - Cyxone
Cyxone in media; Company Presentations; Events; Corporate governance. According to the Articles of Association, the company board shall consist of at least three and at most eight …See details»
Cyxone - LinkedIn
Cyxone AB is a clinical biotech company with a portfolio of immunomodulating drugs for the treatment of autoimmune diseases such as multiple sclerosis (MS) and rheumatoid arthritis (RA).See details»
Cyxone AB (publ) (STO: CYXO) Company Profile & Overview
Nov 22, 2024 Cyxone AB (publ), a clinical stage biotech company, develops disease modifying therapies for autoimmune and autoinflammatory diseases. Its product pipeline comprises …See details»
Cyxone - The Org
Cyxone is a clinical biotech company with a portfolio of immunomodulating drugs for the treatment of autoimmune diseases.See details»
Cyxone Company Profile - Office Locations, Competitors, Revenue …
Cyxone is a biotech company that develops disease modifying therapies for diseases such as rheumatoid arthritis and multiple sclerosis. It develops pipeline drug products such as …See details»
Cyxone - Org chart | The Org
Explore Cyxone's organizational chart. Discover current team members including executives, board members, and advisors.See details»
Cyxone Switzerland AG - Swiss Biotech
Cyxone develops novel drugs to improve quality of life for patients suffering from autoimmune diseases. Cyxone AB is a clinical biotech company with a portfolio of immunomodulating drugs …See details»
Org Chart Cyxone - The Official Board
The organizational chart of Cyxone displays its 9 main executives including Kjell StenbergSee details»
Start - Cyxone
Nov 26, 2024 Cyxone utvecklar nya innovativa terapier för behandling av reumatoid artrit och multipel skleros. Vi har som mål att med våra läkemedel ge ökad livskvalitet för patienter som …See details»
Cyxone - Company Profile - Tracxn
Sep 2, 2024 Cyxone; Navigate to. Overview Competitors Global Equivalents All Related Reports. You are being shown a subset of the data for this profile. Signup and get free access. …See details»
Cyxone Company Profile 2024: Stock Performance & Earnings
The current market capitalization of Cyxone is $618K. What is Cyxone’s annual earnings per share (EPS)? Cyxone’s EPS for 12 months was -$0.01. Data Transparency. Meet our data …See details»
Cyxone AB - VentureRadar
Cyxone develops disease modifying therapies for rheumatoid arthritis and multiple sclerosis as well as treatments for virally induced acute respiratory disorders. With three unique programs, …See details»
Cyxone AB (publ) (CYXO.ST) - Yahoo Finance Canada
See the company profile for Cyxone AB (publ) (CYXO.ST) including business summary, industry/sector information, number of employees, business summary, corporate governance, …See details»
Cyxone AB, CYXO:STO profile - FT.com - Financial Times
Nov 21, 2024 Cyxone AB is a Sweden-based company, which is primarily focused on specialty pharmaceuticals industry. The Company develops cyclotide drugs for autoimmune and other …See details»
Cyxone - Overview, News & Similar companies | ZoomInfo.com
Jan 15, 2024 Cyxone (publ), a biotech company in autoimmune diseases announces that the European Patent Office (EPO) has issued an intention to grant communication for a unitary …See details»
Financial Reports - Cyxone
Jan 1, 2021 Annual Report from Cyxone AB for the period 1 January 2022 to 31 December 2022. 2023-04-27. Regulatory. Year-end Report 1 January to 31 December 2022. 2023-02-17. …See details»